Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments
Topics: Autoimmune, Multiple Sclerosis (MS), Research & Development
|
Multiple Sclerosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Topics: Multiple Sclerosis (MS), Drug Discovery
|
Multiple Sclerosis – Pipeline Review, H1 2012
Topics: Multiple Sclerosis (MS), Drug Discovery
|
Analysis of the European Multiple Sclerosis Market
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
Regions: Europe
|
Special Report: Market Opportunities in Symptomatic Treatments of Multiple Sclerosis
Topics: Multiple Sclerosis (MS), Generics Drugs
|
Multiple Sclerosis Treatment: World Drug Market 2012-2022
Topics: Multiple Sclerosis (MS), Manufacturing, Packaging & Detailing
|
Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010
Topics: Multiple Sclerosis (MS), Drug Discovery, CNS/Neurology
|
Multiple Sclerosis - Pipeline Review, H2 2011
Topics: Multiple Sclerosis (MS)
|
Hot Topics in Multiple Sclerosis: US Prescriber Perception of Biosimilars - Brands to lose over a fifth of patients to copy-cat drugs
Topics: Biosimilars, Multiple Sclerosis (MS)
Regions: United States
|
Hot Topics in Multiple Sclerosis: US Prescriber Perception of Biosimilars - Brands to lose over a fifth of patients to copy-cat drugs
Topics: Biosimilars, Multiple Sclerosis (MS)
Regions: United States
|
Prescribing Influences: Multiple Sclerosis - Therapies that reverse neuronal damage are most sought after
Topics: Multiple Sclerosis (MS)
|
Product Profiles: Multiple Sclerosis - Gilenya raises bar for new market entrants
Topics: Multiple Sclerosis (MS)
|
Autoimmune Diseases: Pipelines for Crohn's Disease, Multiple Sclerosis and Rheumatoid Arthritis
Topics: Multiple Sclerosis (MS), Crohn's
|
R&D Trends: Multiple Sclerosis - Progressive subtypes remain underserved in expansive pipeline
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
|
Gilenya (Fingolimod), Laquinimod and Cladribine - Impact on the Multiple Sclerosis (MS) Treatment Landscape
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
|
Epidemiology: Multiple Sclerosis
Topics: Multiple Sclerosis (MS)
|
Multiple Sclerosis Therapy Area Pipeline Report
Topics: Multiple Sclerosis (MS)
|
Multiple Sclerosis - Pipeline Review, Q1 2011
Topics: Multiple Sclerosis (MS), Drug Discovery
|
Multiple Sclerosis Therapy Pipeline Report
Topics: Multiple Sclerosis (MS), Drug Discovery
|
Multiple Sclerosis - Pipeline Review, Q4 2010
Topics: Multiple Sclerosis (MS)
|
Disease and Therapy Review: Multiple Sclerosis
Topics: Multiple Sclerosis (MS), CNS/Neurology
Regions: Global
|
Multiple Sclerosis Drug Discoveries: What the Future Holds
Topics: Multiple Sclerosis (MS)
|
Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Global Markets
Topics: Multiple Sclerosis (MS), Drug Discovery, Biopharmaceuticals
Regions: Global
|
Multiple Sclerosis Market Forecast
Topics: Multiple Sclerosis (MS)
|
Multiple Sclerosis Therapeutics
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
Regions: Global
|
Global Multiple Sclerosis Drug Market 2010-2025
Topics: Multiple Sclerosis (MS), Research & Development, CNS/Neurology
Regions: Global
|
Central Nervous System Multiple Sclerosis Therapy Area Pipeline Report
Topics: Autoimmune, Multiple Sclerosis (MS), CNS/Neurology
|
The Global Multiple Sclerosis Market 2009-2024
Topics: Autoimmune, Multiple Sclerosis (MS), CNS/Neurology
|
Multiple Sclerosis Treatment Market: Opportunities for Oral Drugs
Topics: Autoimmune, Multiple Sclerosis (MS), Drug Discovery, CNS/Neurology
|
mediKOL Insight: Where next for MS?
Topics: Autoimmune, Multiple Sclerosis (MS), Drug Discovery, CNS/Neurology
|
CNS Drug Discoveries: Multiple Sclerosis Chapter
Topics: Multiple Sclerosis (MS), Drug Discovery, CNS/Neurology
|
Trial TRAX Multiple Sclerosis Clinical Trial Monitoring Brief
Topics: Autoimmune, Multiple Sclerosis (MS), Research & Development, Drug Discovery, CNS/Neurology
|
U.S. Multiple Sclerosis Markets
Topics: Autoimmune, Multiple Sclerosis (MS), Drug Discovery, CNS/Neurology
Regions: United States
|
Multiple Sclerosis Market Analysis & Forecasts Report 2007-2022
Topics: Autoimmune, Multiple Sclerosis (MS), Drug Discovery, CNS/Neurology
Regions: Global
|
Multiple Sclerosis Treatments: World Market Outlook to 2011
Topics: Autoimmune, Multiple Sclerosis (MS), Prescription Drugs, CNS/Neurology, Women's Health
Regions: Global
|
Therapeutic Clinical Intelligence-Multiple Sclerosis
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery, CNS/Neurology
|
Brands & Strategies: Multiple Sclerosis
Topics: Autoimmune, Multiple Sclerosis (MS), Drug Discovery
|
Multiple Sclerosis: Selections from "The World Market for Neurotherapeutic Drugs"
Topics: Autoimmune, Multiple Sclerosis (MS), CNS/Neurology, Women's Health
Regions: Global
|
